Education
About Us
Working with TipRanks
Follow Us
LENZ Therapeutics (LENZ)
NASDAQ:LENZ
Aceclidine+Brimonidine Combination Ophthalmic Solution, Aceclidine Ophthalmic Solution
Presbyopia, Eye Diseases, Near Vision, Miosis
Phase III
Completed
Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia
Sep 13, 2023
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does LENZ Therapeutics (LENZ) have in its pipeline
LENZ is currently developing the following drugs: Aceclidine+Brimonidine Combination Ophthalmic Solution, Aceclidine Ophthalmic Solution. These drug candidates are in various stages of clinical development as the company works toward FDA approval.